Skip to content

Taddese Menassie

Reporting owner on Forms 3, 4 and 5, CIK 1848805.

Taddese Menassie reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-04.

Issuers

IssuerRoles in the latest filingFilingsLast filed
XERS · Xeris Biopharma Holdings, Inc.CIK 1867096director12026-11-04

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
XERS · Xeris Biopharma Holdings, I…Common Stock2026-11-02A granted+22,365$022,365Form 4
XERS · Xeris Biopharma Holdings, I…Stock Option (Right to Buy), derivative2026-11-02A granted-31,499$10.1731,499Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001867096-26-000105 Xeris Biopharma Holdings, Inc.2026-11-04
Form 3 0001867096-26-000103 Xeris Biopharma Holdings, Inc.2026-11-04